Media and Investors Resources
Press Release, 27 February 2017
Kuros receives clearance from the US FDA for MagnetOs allowing marketing in the United States
Press Release, 8 February 2017
Kuros achieves ISO certification for surgical sealants
Press Release, 25 January 2017
Kuros closes acquisition of Xpand creating a leading commercial-stage orthobiologics company
Press Release, 21 December 2016
Kuros submits regulatory filing seeking CE certification for Neuroseal, a novel dural sealant
Press Release, 19 December 2016
Kuros to acquire Xpand in an all-share strategic transaction to create a leading commercial stage orthobiologics company
Press Release, 20 October 2016
Kuros Biosciences' KUR-112 Receives Rare Pediatric Disease Designation